Generali Asset Management SPA SGR purchased a new stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 35,466 shares of the technology company's stock, valued at approximately $6,393,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of AMETEK by 4.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,450 shares of the technology company's stock worth $261,000 after purchasing an additional 63 shares during the period. Kensington Investment Counsel LLC boosted its holdings in shares of AMETEK by 0.5% in the 4th quarter. Kensington Investment Counsel LLC now owns 14,277 shares of the technology company's stock worth $2,574,000 after purchasing an additional 66 shares during the period. AlphaMark Advisors LLC boosted its holdings in shares of AMETEK by 2.1% in the 4th quarter. AlphaMark Advisors LLC now owns 3,348 shares of the technology company's stock worth $604,000 after purchasing an additional 70 shares during the period. Geneos Wealth Management Inc. boosted its holdings in shares of AMETEK by 42.9% in the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company's stock worth $42,000 after purchasing an additional 70 shares during the period. Finally, Quotient Wealth Partners LLC boosted its holdings in shares of AMETEK by 3.9% in the 4th quarter. Quotient Wealth Partners LLC now owns 1,843 shares of the technology company's stock worth $332,000 after purchasing an additional 70 shares during the period. Hedge funds and other institutional investors own 87.43% of the company's stock.
AMETEK Stock Down 0.8 %
Shares of NYSE AME traded down $1.43 during mid-day trading on Friday, reaching $174.50. 1,422,601 shares of the company were exchanged, compared to its average volume of 1,160,636. The company has a quick ratio of 0.75, a current ratio of 1.24 and a debt-to-equity ratio of 0.15. The stock has a market cap of $40.26 billion, a price-to-earnings ratio of 29.43, a P/E/G ratio of 2.73 and a beta of 1.14. AMETEK, Inc. has a 1 year low of $149.03 and a 1 year high of $198.33. The firm has a 50-day moving average of $182.92 and a 200 day moving average of $180.43.
AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.87 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.02. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.82 billion. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. The firm's quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.68 EPS. On average, research analysts expect that AMETEK, Inc. will post 7.15 earnings per share for the current year.
AMETEK announced that its board has approved a share repurchase plan on Friday, February 7th that allows the company to repurchase $1.25 billion in shares. This repurchase authorization allows the technology company to purchase up to 2.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its stock is undervalued.
AMETEK Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be paid a dividend of $0.31 per share. This is a boost from AMETEK's previous quarterly dividend of $0.28. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Friday, March 14th. AMETEK's dividend payout ratio is 20.91%.
Insider Buying and Selling
In other AMETEK news, Director Steven W. Kohlhagen sold 1,320 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $189.41, for a total value of $250,021.20. Following the completion of the sale, the director now directly owns 22,029 shares in the company, valued at approximately $4,172,512.89. This trade represents a 5.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.61% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of equities analysts have recently commented on the company. KeyCorp lifted their target price on AMETEK from $205.00 to $215.00 and gave the stock an "overweight" rating in a report on Friday, November 22nd. Bank of America raised AMETEK from a "neutral" rating to a "buy" rating and raised their price target for the stock from $195.00 to $225.00 in a research note on Monday, December 16th. Truist Financial raised their price target on AMETEK from $221.00 to $222.00 and gave the stock a "buy" rating in a research note on Thursday, January 16th. StockNews.com raised AMETEK from a "hold" rating to a "buy" rating in a research note on Sunday, March 9th. Finally, BNP Paribas raised AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 price target for the company in a research note on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $204.67.
View Our Latest Stock Analysis on AME
About AMETEK
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report